Holen Sie sich die Stockscreener-App
4.30
2.72%
-0.11
Schlusskurs vom Vortag:
$4.41
Offen:
$4.4
24-Stunden-Volumen:
35,856
Relative Volume:
0.22
Marktkapitalisierung:
$46.11M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.25M
KGV:
-2.4157
EPS:
-1.78
Netto-Cashflow:
$-17.87M
1W Leistung:
-5.71%
1M Leistung:
+12.01%
6M Leistung:
+21.53%
1J Leistung:
+20.85%
1-Tages-Spanne:
$4.0705
$4.41
1-Wochen-Bereich:
$4.0705
$4.7034
52-Wochen-Spanne:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Firmenname
Lantern Pharma Inc
Sektor
Branche
Telefon
972-277-1136
Adresse
1920 MCKINNEY AVENUE, DALLAS, TX
Vergleichen Sie LTRN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
4.27 | 46.87M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
410.51 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
472.81 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.36 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
794.98 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
322.71 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-07 | Eingeleitet | H.C. Wainwright | Buy |
Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten
How to build a custom watchlist for Lantern Pharma Inc.July 2025 EndofMonth & Risk Controlled Stock Alerts - newser.com
Technical analysis overview for Lantern Pharma Inc. stockQuarterly Market Summary & Stepwise Entry/Exit Trade Alerts - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesQuarterly Profit Report & Free Real-Time Volume Trigger Notifications - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - GoUpstate
Trend analysis for Lantern Pharma Inc. this week2025 Market Overview & Daily Price Action Insights - newser.com
Has Lantern Pharma Inc. formed a bullish divergenceForecast Cut & Free Weekly Chart Analysis and Trade Guides - newser.com
Lantern Pharma (NASDAQ: LTRN) CEO Panna Sharma and New Board Member Dr. Lee Schalop Discuss How AI Can Reshape CNS Oncology Drug Development - Digital Journal
Using economic indicators to assess Lantern Pharma Inc. potentialWeekly Stock Summary & Weekly High Potential Alerts - newser.com
When is the best time to exit Lantern Pharma Inc.Entry Point & Long-Term Safe Investment Plans - newser.com
Will Lantern Pharma Inc. stock recover after recent drop2025 Top Gainers & Community Verified Swing Trade Signals - newser.com
Lantern Pharma (NASDAQ:LTRN) Trading Down 6.1% – Here’s What Happened - Defense World
Lantern Pharma (NASDAQ:LTRN) Rating Increased to Hold at Wall Street Zen - Defense World
Can momentum traders help lift Lantern Pharma Inc.Market Sentiment Review & Comprehensive Market Scan Reports - newser.com
Visual analytics tools that track Lantern Pharma Inc. performanceJuly 2025 Snapshot & Capital Efficient Trading Techniques - newser.com
Why Lantern Pharma Inc. is moving todayMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Using flow based indicators on Lantern Pharma Inc.July 2025 Summary & Real-Time Volume Triggers - newser.com
Is Lantern Pharma Inc. stock a buy for dividend growthJuly 2025 Movers & Real-Time Volume Analysis - newser.com
What’s the recovery path for long term holders of Lantern Pharma Inc.July 2025 WrapUp & AI Enhanced Trading Alerts - newser.com
Lantern Pharma Inc. stock prediction for this weekEarnings Trend Report & Daily Profit Maximizing Tips - newser.com
Is Lantern Pharma Inc. showing signs of accumulation2025 Market Outlook & Verified Short-Term Trading Plans - newser.com
Lantern Pharma Inc.’s volatility index tracking explainedJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com
What analysts say about Lantern Pharma Inc stockBullish Engulfing Patterns & Backtest Your Strategy Before You Risk Money - earlytimes.in
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lantern Pharma Inc-Aktie (LTRN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | 10% Owner |
Jun 13 '25 |
Sale |
3.09 |
40,000 |
123,600 |
49,957 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Kreis Leslie W. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Kreis Leslie W. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Kreis Leslie W. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Fletcher Aaron G.L. | 10% Owner |
May 27 '25 |
Sale |
3.05 |
21,037 |
64,163 |
56,467 |
| Fletcher Aaron G.L. | 10% Owner |
May 29 '25 |
Sale |
3.03 |
20,200 |
61,206 |
54,792 |
| Fletcher Aaron G.L. | 10% Owner |
May 28 '25 |
Sale |
2.87 |
15,000 |
43,050 |
55,753 |
5.02%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):